Text: MARYLAND CITIZENS' HEALTH INITIATIVE
facebook icon twitter icon rss icon
Text: Follow Us
Text: Working to win quality, affordable health care for all Marylanders

Judge: Maryland can act against drug price-gouging, for now

October 2, 2017

Star Tribune Brian Witte September 29, 2017 ANNAPOLIS, Md. — An effort by drug makers to block Maryland’s first-in-the-nation law against pharmaceutical price gouging was denied by a federal judge on Friday. A group representing makers of generic prescription drugs sought to stop the law from taking effect this Sunday, calling it an “unconstitutional overreach” […]... Read more »

Don’t let pharma take down a new Maryland price gouging law

September 11, 2017

Washington Post Jeremy A. Greene – Op-Ed September 8th 2017 Jeremy A. Greene is a professor of medicine and the history of medicine at the Johns Hopkins University School of Medicine and the author of “Generic: The Unbranding of Modern Medicine.” In May, Maryland became the first state to take action against the alarming trend […]... Read more »

Share your story about prescription drug price gouging

June 5, 2017

Thanks to a law passed by the Maryland General Assembly in 2017, Attorney General Brian Frosh can take action against pharmaceutical corporations who manufacture generic or off-patent drugs if they raise the price of the drug without justification and in a way that makes it hard for people using the drug to afford it. Are […]... Read more »

As States Wage Battles on High Drug Prices, Drugmakers Fight Back

May 17, 2017

Maryland’s legislature in April approved a bill that would allow the state attorney general to sue manufacturers of generic drugs for price increases deemed to be excessive; the governor is reviewing it, a spokeswoman said.... Read more »

What is Hogan waiting for?

May 9, 2017

Maryland would be the first state have such a law if Gov. Larry Hogan signs the Frosh bill – or even if he allows the bill to become law without his signature.... Read more »

Maryland on-track to give attorney general power to sue for drug price-gouging

Washington Post April 10, 2017 Ovetta Wiggins and Josh Hicks Maryland could become the first state to give its attorney general the power to take legal action against drug companies that dramatically increase the price of off-patent or generic drugs under a measure that is moving through the General Assembly. Attorney General Brian E. Frosh […]... Read more »

“Unconscionable” drug price spikes could soon be stopped in one state

CBS National April 11, 2017 Maryland would be the first state to empower the state’s attorney general to take action to stop pharmaceutical price gouging under a measure given final passage by lawmakers on Monday. The bill sent to Republican Gov. Larry Hogan would enable the attorney general to bring civil actions against manufacturers of off-patent […]... Read more »

Maryland Lawmakers Approve Bill To Fight Drug Price-Gouging

Reuters and Huffington Post April 10, 2017 Ian Simpson  Maryland lawmakers have passed a first-in-the-nation measure that lets the state attorney general sue generic drug makers that sharply raise prices in a move aimed at fighting what legislators call “price-gouging.” The bill overwhelmingly was approved by the Democratic-controlled legislature on Monday and hailed by Maryland […]... Read more »

Maryland lawmakers send bill on drug price gouging to Hogan

Baltimore Business Journal April 10, 2017 Morgan Eichensehr The Maryland General Assembly has passed a bill intended to fight unwarranted price hikes on “essential” generic drugs. If signed by Gov. Larry Hogan, the bill would make it illegal for generic drug manufacturers to engage in price gouging — defined as an “unconscionable increase in price” […]... Read more »

Lawmakers approve drug “price gouging” bill

WYPR April 12, 2017 Brendan Reynolds Hours before adjourning for the year, state lawmakers approved a first in the nation bill that would allow Maryland’s Attorney General to sue the makers of generic drugs over sharp rice increases—or price gouging. It was part of an effort to hold down the sharply escalating prices of generic […]... Read more »